Thyroid cytopathology: Bethesda System 2010

被引：6

作者：

Cochand-Priollet, Beatrix ^{[1
]}

Vielh, Philippe ^{[2
]}

Royer, Benedicte ^{[3
]}

Belleannee, Genevieve ^{[4
]}

Collet, Jean-Francois ^{[5
]}

Goubin-Versini, Isabelle ^{[6
]}

Leteurtre, Emmanuelle ^{[7
]}

机构：

[1] Univ Paris 07, Serv Anat & Cytol Pathol, Hop Lariboisiere, F-75745 Paris 10, France

[2] Inst Cancerol Gustave Roussy, Unite Cytopathol, Dept Biopath, F-94805 Villejuif, France

[3] Ctr Pathol & Imagerie, F-75014 Paris, France

[4] Hop Haut Leveque, Serv Anat & Cytol Pathol, F-33604 Pessac, France

[5] Cabinet Cytopathol, F-75015 Paris, France

[6] CHR Dubos, Serv Anat & Cytol Pathol, F-95303 Cergy Pontoise, France

[7] Ctr Biol Pathol, Inst Pathol, F-59037 Lille, France

来源：

ANNALES DE PATHOLOGIE | 2012年 / 32卷 / 03期

关键词：

Terminology; Bethesda; Thyroid; Cytopathology; GUIDELINES; NODULES; CANCER;

D O I：

10.1016/j.annpat.2012.02.015

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

When considering the number of thyroid fine-needle aspirations performed not only in France but also in the world, then thyroid pathology, as well as Papsmears, represents the main pathology based on cytological diagnoses. Decisions of clinical follow-up or of surgical treatments will be done based on the cytological results. Until recently, neither official nor consensual terminology has been adopted despite classifications by experts having been proposed. The Bethesda terminology, published in 2010, in English, is linked with a percentage of risk cancer for each of its diagnostic category and with a suitable treatment. Furthermore, this terminology allows the possibility of standardized management for the patients and the opportunity of further assessment of the cytological diagnoses. Therefore, the French Society of Clinical Cytology has decided to publish this official French version of the Bethesda terminology. Its use is highly recommended. (C) 2012 Published by Elsevier Masson SAS.

引用

页码：177 / 183

页数：7

共 10 条

[1] FNAC Thyroid Reporting Categories: Value of Using the British Thyroid Association (Thy 1 to Thy 5) Thyroid FNAC Reporting Guidelines
Agarwal, A.
Kocjan, G.
[J]. CYTOPATHOLOGY, 2009, 20 (02) : 133 - 134
[2] Thyroid Cytopathology: Bethesda and Beyond
Ali, Syed Z.
[J]. ACTA CYTOLOGICA, 2011, 55 (01) : 4 - 12
[3] Ali SZ., 2010, The Bethesda System for Reporting Thyroid Cytopathology
[4] [Anonymous], 2006, ENDOCR PRACT
[5] [Anonymous], DIAGN CYTOPATHOL
[6] DeLellis R.A., 2004, PATHOLOGY GENETICS T, P50
[7] Utilization of ancillary studies in thyroid Fine Needle Aspirates: A Synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference
Filie, Armando C.
Asa, Sylvia L.
Geisinger, Kim R.
Logani, Sanjay
Merino, Maria
Nikiforov, Yuri E.
Clark, Douglas R.
[J]. DIAGNOSTIC CYTOPATHOLOGY, 2008, 36 (06) : 438 - 441
[8] Guidelines of the Papanicolaou Society of Cytopathology for the Examination of Fine-Needle Aspiration Specimens from Thyroid Nodules, 1996, MODERN PATHOL, V9, P710
[9] Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009
Kocjan, G.
Cochand-Priollet, B.
de Agustin, P. P.
Bourgain, C.
Chandra, A.
Daneshbod, Y.
Deery, A.
Duskova, J.
Ersoz, C.
Fadda, G.
Fassina, A.
Firat, P.
Jimenez-Ayala, B.
Karakitsos, P.
Koperek, O.
Matesa, N.
Poller, D.
Thienpont, L.
Ryska, A.
Schenck, U.
Sauer, T.
Schmitt, F.
Tani, E.
Toivonen, T.
Toetsch, M.
Troncone, G.
Vass, L.
Vielh, P.
[J]. CYTOPATHOLOGY, 2010, 21 (02) : 86 - 92
[10] Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
Smith, BR
Cooper, DS
Doherty, GM
Haugen, BR
Kloos, RT
Lee, SL
Mandel, SJ
Mazzaferri, EL
McIver, B
Sherman, SI
Tuttle, RM
[J]. THYROID, 2006, 16 (02) : 109 - +

← 1 →